A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
- Status
- RECRUITING
- Phase
- N/A
Mavacamten in Obstructive Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- N/A
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Status
- RECRUITING
- Phase
- PHASE3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Status
- RECRUITING
- Phase
- N/A
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Luspatercept + Darbepoetin in MDS
- Status
- RECRUITING
- Phase
- PHASE2
Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept
- Status
- COMPLETED
- Phase
- N/A
Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China
- Status
- COMPLETED
- Phase
- N/A